
Keywords: MS; multiple sclerosis; GM; gray matter; HFE; human hemochromatosis gene; QSM; quantitative susceptibility mapping; HC; healthy control; RRMS; relapsing-remitting multiple sclerosis; EDSS; Expanded Disability Status Scale; TF; transferrin; SNP; single nuc